GlassScriptPhysician profile
Craig M Meier
NPI 1740330745
$8,428.75
in general payments reported to CMS, 2019-2025
70 companies · $1,077 in 2025
The $1,077 reported for 2025 was more than what 87% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,533 · 2020: $1,173 · 2021: $1,582 · 2022: $1,276 · 2023: $1,006 · 2024: $781 · 2025: $1,077.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,756 · Education: $107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,756.40 |
| Education | $107.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,231.42 | 2021-2025 | |
| Amgen INC. | $1,041.99 | 2019-2025 | Evenity, Prolia, Otezla |
| Astrazeneca Pharmaceuticals LP | $750.44 | 2019-2025 | Airsupra, Xigduo, Fasenra |
| Novo Nordisk INC | $650.22 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Amarin Pharma, INC. | $456.10 | 2019-2021 | |
| Lilly USA, LLC | $293.25 | 2019-2025 | Mounjaro, Jardiance, Emgality |
| Antares Pharma, INC. | $272.68 | 2019-2023 | Xyosted, Nocdurna, Tlando |
| Allergan, INC. | $260.94 | 2019-2020 | |
| Pfizer INC. | $245.75 | 2020-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $234.54 | 2022-2025 | |
| Sanofi-Aventis U.S. LLC | $217.83 | 2019-2023 | |
| Otsuka America Pharmaceutical, INC. | $215.89 | 2022-2025 | Rexulti |
| Novartis Pharmaceuticals Corporation | $187.50 | 2023-2025 | |
| Harmony Biosciences LLC | $135.04 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $127.86 | 2022-2025 | Gardasil 9, Capvaxive, Vaxneuvance |
Show all 70 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Meier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.